Literature DB >> 8520062

Cycloserine-induced lichenoid drug eruption.

J H Shim1, T Y Kim, H O Kim, C W Kim.   

Abstract

A 65-year-old male patient who has taken antituberculous drugs including cycloserine for 8 months showed multiple pruritic, violaceous, flat-topped papules and plaques on his back which had developed 5 months into therapy. Histopathologic findings were consistent with lichenoid drug eruption. Patch test with the drugs revealed a strongly positive reaction to cycloserine only. Four months after discontinuation of oral cycloserine, pruritus resolved and the lesions subsided without any new lesions. Cycloserine is one of the antituberculous drugs. Skin manifestations resulting from its administration are reported to be rare, but to our knowledge, this is the first case report of lichenoid drug eruption from its use.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520062     DOI: 10.1159/000246533

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

Review 1.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

2.  Lichenoid Drug Eruption Progressing into Erythroderma in A Case of Cervical Scrofuloderma Due to Multi Drug-Resistant Tuberculosis.

Authors:  Mahendra M Kura; Anmol Sodhi; Snehal Chavhan; Priya Kadu
Journal:  Indian J Dermatol       Date:  2022 Jan-Feb       Impact factor: 1.757

3.  A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported by the Lymphocyte Transformation Test.

Authors:  Jakyoung Kim; Shinyoung Park; Chul Min Jung; Chee Won Oh; Jae Woo Kwon
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.